Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty. | Zendy

Daniel B. Mark | Zendy; Charlotte Nelson | Zendy; Robert M. Califf | Zendy; Frank E. Harrell | Zendy; K L Lee | Zendy; Robert H. Jones | Zendy; Donald F. Fortin | Zendy; Richard S. Stack | Zendy; Donald D. Glower | Zendy; Leanne Smith | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty.

Author(s) -

Daniel B. Mark,

Charlotte Nelson,

Robert M. Califf,

Frank E. Harrell,

K L Lee,

Robert H. Jones,

Donald F. Fortin,

Richard S. Stack,

Donald D. Glower,

Leanne Smith

Publication year - 1994

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/01.cir.89.5.2015

Subject(s) - medicine , coronary artery disease , revascularization , angioplasty , cardiology , hazard ratio , prospective cohort study , cardiac catheterization , cohort , randomized controlled trial , surgery , myocardial infarction , confidence interval

Survival after coronary artery bypass graft surgery (CABG) and medical therapy in patients with coronary artery disease (CAD) has been studied in both randomized trials and observational treatment comparisons. Over the past decade, the use of coronary angioplasty (PTCA) has increased dramatically, without guidance from either randomized trials or prospective observational comparisons. The purpose of this study was to describe the survival experience of a large prospective cohort of CAD patients treated with medicine, PTCA, or CABG.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research